Tag: semaglutide
Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes
A real-world analysis of 60,000 adults with type 2 diabetes shows semaglutide users experienced 15% fewer bone fractures than those…
Weekly semaglutide outperforms dulaglutide for diabetes control in UK primary care study
Large UK study shows weekly semaglutide provides superior blood sugar control and weight loss compared to dulaglutide in type 2…
GLP-1 Weight-Loss Drugs Reduce Breast Cancer Risk by 17% in Largest Study to Date
New research from ASCO 2026 shows GLP-1 weight-loss medications reduce breast cancer risk by 17% and cancer mortality by 24%…
Weight Loss Expert Raises Safety Concerns Over Unregulated GLP-1 ‘Microdoses’
Weight-loss specialist warns about unregulated GLP-1 microdosing trend lacking clinical trial evidence. Long-term safety effects remain unknown for reduced-dose formulations.
Scientists Discover Why Ozempic and Wegovy Weight Loss Plateaus After Initial Success
NIH scientists have discovered why GLP-1 weight-loss medications like Ozempic and Wegovy eventually plateau, with 47% of patients experiencing reduced…
Wegovy Shows Higher Risk of Rare Eye Stroke Causing Sudden Vision Loss
New FDA database analysis reveals Wegovy carries 5x higher risk of rare eye stroke compared to Ozempic. Higher weight-loss doses…